Monday, March 4, 2024
6:45am | Registration / Continental Breakfast | |
Princess Ballroom | ||
7:20am | Welcome and Opening Remarks | |
Mykl Garrett, RPH, MBA, FACHE | ||
Princess Ballroom | ||
Cases Over Coffee I: Case Presentation and Expert CommentaryModerator: Andrew M. Goldsweig, MD | ||
7:30 am | TAV-in-TAV: When in Doubt, Find a UNICORN | |
Molly Szerlip, MD | ||
7:40 am | Case 2: Navigating the Challenges and Complications of LAAO | |
Srinivas Iyengar, MD | ||
7:50 am | Case 3: Seeing the Invisible: Invasive Coronary Microcirculatory Testing | |
Ankur Gupta, MD, PhD | ||
Structural Heart Therapies Session IModerator: John M. Lasala, MD, PhD | ||
8:00 am | Top Structural Trials of the Last Year | |
Andrew M. Goldsweig, MD | ||
8:15 am | ICE-Guided LAA Mechanical Closure | |
John M. Lasala, MD, PhD | ||
8:30 am | Expanding the Indications for Left Atrial Appendage Mechanical Therapies | |
Matthew W. Sherwood, MD, MHS | ||
8:45 am | PFO and Paradoxical Embolus: Embryology to Transcatheter Device Closure | |
James A. Goldstein, MD | ||
Live Cases 1 & 2 | LAA and MITRALModerators: John M. Lasala, MD, PhD and Brian K. Whisenant, MD | ||
9:00 am | Case 1 | |
Broadcast from HonorHealth Shea Medical Center, Scottsdale, Arizona | ||
Operator: Rahul N. Doshi, MD | ||
9:35 am | Case 2 | |
Broadcast from HonorHealth Shea Medical Center, Scottsdale, Arizona | ||
Operator: David G. Rizik, MD | ||
10:15am | Break / Visit Exhibits | |
Structural Heart Therapies IIModerator: Kendra J. Grubb, MD | ||
FLASH DEBATERevascularization Prior to Valve Therapy: | ||
10:30 am | A Must in Most Cases | |
John M. Lasala, MD, PhD | ||
10:36 am | No Way: Can We Just Get to the Valve Implant? | |
Matthew W. Sherwood, MD | ||
10:42 am | Wrap-up | |
10:45 am | LAMPOON and SESAME: Leaflet Modification Strategies in TMVR | |
Jason Foerst, MD | ||
11:00 am | Comparing Long-term Outcomes: Valve-in-Valve, Valve-in-Ring, Valve-in-MAC | |
Jonathan G. Schwartz, MD | ||
11:15 am | Managing TMVR Migration/Embolization | |
Kendra J. Grubb, MD | ||
11:30 am | Cephea, Intrepid and Evoque Program Updates | |
James B. Hermiller, MD | ||
11:45 am | Innovalve: A New “Twist” in Valve Therapy | |
David G. Rizik, MD | ||
12:00 pm | LUNCH / VISIT EXHIBITS | |
Pick-Up Lunch and Return to the Ballroom | ||
Working Lunch: Structural Heart Therapies III: Emerging Catheter-Based Strategies in Structural InterventionModerators: Mark Reisman, MD | ||
12:30 pm | The Landscape of Emerging Tricuspid Therapies | |
Mark Reisman, MD | ||
12:45 pm | Forgotten No More: Screening for Tricuspid TEER | |
Srinivas Iyengar, MD | ||
1:00 pm | The Evolving Use of Intravascular Lithotripsy in Valvular Heart Disease | |
Dean J. Kereiakes, MD (virtual-live) | ||
1:15 pm | Technologies for Treating Left Atrial Decompression in Heart Failure | |
Steven R. Bailey, MD | ||
Live Case 3Moderators: Steven J. Yakubov, MD and Jamie M. McCabe, MD | ||
1:30 pm | Case 3 | |
Broadcast from HonorHealth Shea Medical Center, Scottsdale, Arizona | ||
Operator: David G. Rizik, MD Guest Operator: James B. Hermiller, MD | ||
2:15 pm | BREAK / VISIT EXHIBITS | |
STRUCTURAL HEART THERAPIES IV: TAVR-IN-TAVR WORKSHOPModerator: Michael J. Rinaldi, MD | ||
2:30 pm | Optimization of the Initial TAVR for Best Durability and Planning the Next Valve | |
Molly Szerlip, MD | ||
2:45 pm | TAVR-in-TAVR: The Evidence for Leaflet Modification | |
Carlos E. Sanchez, MD | ||
3:00 pm | Tips and Tricks: Implantation Techniques for TAVR-in-TAVR | |
Megan Coylewright, MD | ||
3:15 pm | Are All Transcatheter Valve System Options Possible for TAVR-in-TAVR? | |
Steven J. Yakubov, MD | ||
3:30 pm | Putting It All Together: TAVR-in-TAVR Case Presentation | |
Philippe Genereux, MD | ||
Controversies Over CockatilsModerators: Steven R. Bailey, MD | ||
Strategies Following Failed TAVR | ||
4:00 pm | Failed TAVR: Next Step Is Device Explant and SAVR | |
Katherine B. Harrington, MD | ||
4:08 pm | Failed TAVR: There’s Almost Always Another Transcatheter Option | |
Jamie M. McCabe, MD | ||
4:16 pm | Wrap Up | |
Low-Risk Aortic Stenosis with Coronary Artery Disease | ||
4:20 pm | TAVR and PCI in Most Cases | |
Michael J. Rinaldi, MD | ||
4:28 pm | SAVR and CABG in Most Cases | |
Kendra Grubb, MD | ||
4:36 pm | Wrap Up | |
4:40 pm | Multimodality Imaging: Implications for the Valve-in-Valve Mitral Procedure | |
Jonathon Leipsic, MD | ||
4:55 pm | Wrap Up | |
5:00 pm | Adjourn CME Session | |
Abbott Sponsored Evening Dinner Symposium Case-Based M-TEER Therapy in 2024Not CME Accredited | ||
5:30 pm | M-TEER Therapy Through the Lens of the Echocardiographer | |
Robert F. Burke, MD | ||
5:45 pm | COAPT 5-year Data and Real-World Applicability | |
Megan Coylewright, MD | ||
6:00 pm | Symptom Improvement and Restoration of Life Expectancy Following M-TEER | |
Steven J. Yakubov, MD | ||
6:15 pm | M-TEER in Patients with Atrial Functional Mitral Regurgitation | |
James B. Hermiller, MD | ||
6:30 pm | M-TEER Therapy in Cardiogenic Shock | |
David G. Rizik, MD | ||
6:45 pm | M-TEER in Patients with Anatomically Complex Degenerative Mitral Regurgitation | |
Mark Reisman, MD | ||
7:00 pm | M-TEER vs. Surgical Repair: What We Hope to Learn from PRIMARY & REPAIR MR | |
Michael J. Rinaldi, MD | ||
7:15 pm | Tricuspid TEER: Putting the Technology and Data into Perspective | |
Ronald Caputo, MD | ||
7:30 pm | Wrap-Up |